These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20414537)

  • 21. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
    Amoah AG; Schuster DP; Gaillard T; Osei K
    Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study.
    Resnick HE; Jones K; Ruotolo G; Jain AK; Henderson J; Lu W; Howard BV;
    Diabetes Care; 2003 Mar; 26(3):861-7. PubMed ID: 12610050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin resistance, the metabolic syndrome and risk of cardiovascular disease: a complex story.
    Issa BG; Hanna FW
    Curr Opin Lipidol; 2003 Aug; 14(4):405-7. PubMed ID: 12865741
    [No Abstract]   [Full Text] [Related]  

  • 24. Correlation Between White Blood Cell Count and Insulin Resistance in Type 2 Diabetes.
    Mahdiani A; Kheirandish M; Bonakdaran S
    Curr Diabetes Rev; 2019; 15(1):62-66. PubMed ID: 29357806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic syndrome in drug-nave Chinese patients with insulin-sensitive and insulin-resistant type 2 diabetes.
    Lin JD
    Ann Saudi Med; 2016; 36(3):203-9. PubMed ID: 27236392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
    Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
    Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of the components of the metabolic syndrome that predispose to diabetes and atherosclerotic CVD.
    Eckel RH
    Proc Nutr Soc; 2007 Feb; 66(1):82-95. PubMed ID: 17343775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks?
    Cleland SJ; Fisher BM; Colhoun HM; Sattar N; Petrie JR
    Diabetologia; 2013 Jul; 56(7):1462-70. PubMed ID: 23613085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should the insulin resistance syndrome be treated in the elderly?
    Grant RW; Meigs JB
    Drugs Aging; 2004; 21(3):141-51. PubMed ID: 14979733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calculating insulin resistance in the primary care setting: why should we worry about insulin levels in euglycemic patients?
    Appel SJ
    J Am Acad Nurse Pract; 2005 Aug; 17(8):331-6. PubMed ID: 16045594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular complications of type 1 diabetes: update on the renal link.
    Orchard TJ; Costacou T
    Acta Diabetol; 2017 Apr; 54(4):325-334. PubMed ID: 27995339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
    Rader DJ
    Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The metabolic syndrome and cardiovascular risk.
    Hu G; Qiao Q; Tuomilehto J
    Curr Diabetes Rev; 2005 May; 1(2):137-43. PubMed ID: 18220589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: a systematic review.
    Cantiello F; Cicione A; Salonia A; Autorino R; De Nunzio C; Briganti A; Gandaglia G; Dell'Oglio P; Capogrosso P; Damiano R
    Int J Urol; 2015 Jan; 22(1):22-32. PubMed ID: 25345683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of endothelial dysfunction in the metabolic syndrome.
    Deedwania PC
    Curr Diab Rep; 2003 Aug; 3(4):289-92. PubMed ID: 12866990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
    Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
    Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular disease in diabetes.
    Zhang PY
    Eur Rev Med Pharmacol Sci; 2014; 18(15):2205-14. PubMed ID: 25070828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of Metabolic Syndrome in Relation to Cardiovascular Biomarkers and Dietary Factors among Adolescents with Type 1 Diabetes Mellitus.
    Grabia M; Markiewicz-Żukowska R; Socha K; Polkowska A; Zasim A; Boruch K; Bossowski A
    Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adipokines, insulin resistance, and adiposity as a predictors of metabolic syndrome in child survivors of lymphoma and acute lymphoblastic leukemia of a developing country.
    Barbosa-Cortés L; López-Alarcón M; Mejía-Aranguré JM; Klünder-Klünder M; Del Carmen Rodríguez-Zepeda M; Rivera-Márquez H; de la Vega-Martínez A; Martin-Trejo J; Shum-Luis J; Solis-Labastida K; López-Aguilar E; Matute-González G; Bernaldez-Rios R
    BMC Cancer; 2017 Feb; 17(1):125. PubMed ID: 28193268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and comorbidities of double diabetes.
    Merger SR; Kerner W; Stadler M; Zeyfang A; Jehle P; Müller-Korbsch M; Holl RW; ;
    Diabetes Res Clin Pract; 2016 Sep; 119():48-56. PubMed ID: 27449710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.